ImYoo partners with Illumina Accelerator to develop technology and launch immune studies

Sep 15, 2021
1 min read

ImYoo was selected as part of a global cohort as part 13th funding cycle of Illumina Accelerator in the San Francisco Bay Area. Read the official press release at Illumina.com:

https://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=2f0d693d-c0bf-4fb8-bb05-f6bce7f9dc7b

Recent Posts

See All

ImYoo releases technical note in partnership with YourBio Health

We have released a technical note describing ImYoo's experimental platform for performing decentralized immune studies with small samples...

ImYoo partners with Jumpcode Genomics

ImYoo has partnered with Jumpcode Genomics to use Jumpcode’s RNA depletion technology to improve data quality and eliminate the...

ImYoo is selected as one of the award winners for the QuickFire Immunology Challenge

ImYoo was selected as one of the award winners for QuickFire Immunology Challenge. As part of the award, ImYoo will receive lab space and...

Comments